- Home
- LE vs INBX Comparison
LE vs INBX Comparison
Compare LE & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LE
- INBX
- Stock Information
- Founded
- LE 1963
- INBX 2010
- Country
- LE United States
- INBX United States
- Employees
- LE N/A
- INBX N/A
- Industry
- LE Clothing/Shoe/Accessory Stores
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- LE Consumer Discretionary
- INBX Health Care
- Exchange
- LE Nasdaq
- INBX Nasdaq
- Market Cap
- LE 440.9M
- INBX 430.2M
- IPO Year
- LE N/A
- INBX 2020
- Fundamental
- Price
- LE $16.35
- INBX $79.16
- Analyst Decision
- LE Strong Buy
- INBX Hold
- Analyst Count
- LE 2
- INBX 2
- Target Price
- LE $20.00
- INBX N/A
- AVG Volume (30 Days)
- LE 141.0K
- INBX 790.6K
- Earning Date
- LE 12-04-2025
- INBX 11-14-2025
- Dividend Yield
- LE N/A
- INBX N/A
- EPS Growth
- LE N/A
- INBX N/A
- EPS
- LE 0.19
- INBX N/A
- Revenue
- LE $1,315,578,000.00
- INBX $1,400,000.00
- Revenue This Year
- LE $2.21
- INBX $563.00
- Revenue Next Year
- LE $2.44
- INBX $230.77
- P/E Ratio
- LE $86.11
- INBX N/A
- Revenue Growth
- LE N/A
- INBX N/A
- 52 Week Low
- LE $7.65
- INBX $10.81
- 52 Week High
- LE $16.87
- INBX $86.64
- Technical
- Relative Strength Index (RSI)
- LE 56.49
- INBX 72.20
- Support Level
- LE $15.39
- INBX $72.00
- Resistance Level
- LE $16.86
- INBX $83.76
- Average True Range (ATR)
- LE 0.67
- INBX 7.89
- MACD
- LE 0.02
- INBX -0.86
- Stochastic Oscillator
- LE 80.32
- INBX 75.33
About LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.